The mission of PPMI is to identify one or more biomarkers of Parkinson’s disease progression. The discovery of a biomarker is a critical step in the development of new and better treatments for PD. This study is being sponsored by The Michael J. Fox Foundation for Parkinson's Research.
"working on efforts to develop models of synucleinopathy." I wish them luck with that As to your other MJFF reference AMBS had not even released the final results at the time and that is why MJFF wanted every one to not misinterpret the PR as you did LOL
"All Truth, In The Long Run, Is Only Common Sense Clarified. ~ Thomas H. Huxley "Facts Do Not Cease To Exist Because They Are Ignored." ~ Aldous Huxley